newsfilter
← Latest News
PR Newswire·

Q32 Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update

Q32 Bio Inc. (NASDAQ: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune...